Targeting Activated Platelets: A Novel Innovative Approach For The Sensitive Detection And Therapeutic Targeting Of Various Cancers And Their Metastases
Funder
National Health and Medical Research Council
Funding Amount
$948,447.00
Summary
Early detection and selective therapy is critical for the survival of patients with cancer. We have shown in pilot experiments that platelets accumulate at the site of tumours and thus provide the opportunity to diagnose and localise cancer and its metastases. Based on this and also newly developed biotechnological tools we aim to develop multiple innovative imaging technologies. Furthermore, we will develop novel tumour-targeted and thus tumour site-specific, side-effect poor cancer treatments.